{"version":"1.0","provider_name":"Department of Medicine","provider_url":"https:\/\/www.med.unc.edu\/medicine","author_name":"Kim Morris","author_url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/","title":"Cavender Talks With Forbes About COVID and Blood Clots | Department of Medicine","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ueY0D6J3q7\"><a href=\"https:\/\/www.med.unc.edu\/medicine\/news\/cavender-talks-with-forbes-about-blood-clots\/\">Cavender Talks With Forbes About COVID and Blood Clots<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.med.unc.edu\/medicine\/news\/cavender-talks-with-forbes-about-blood-clots\/embed\/#?secret=ueY0D6J3q7\" width=\"600\" height=\"338\" title=\"&#8220;Cavender Talks With Forbes About COVID and Blood Clots&#8221; &#8212; Department of Medicine\" data-secret=\"ueY0D6J3q7\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/02\/matt-cavender.jpeg","thumbnail_width":549,"thumbnail_height":768,"description":"Matthew Cavender, MD, MPH, associate professor in the division of cardiology and interventional cardiologist, was interviewed by Forbes magazine, discussing the use of blood thinners for patients with clots related to COVID-19. \u201cCOVID patients are clearly at higher risk of thrombotic events,\u201d said Cavender, in the article. &#8220;Blood thinners certainly play a role in clot &hellip; Read more"}